Business

March 7, 2014 2:43 PM

Durham drug developer Chimerix reports drop in revenue in 4th quarter

Antiviral drug developer Chimerix reported a drop in revenue in the fourth quarter as a result of reduced reimbursements from a federal contract.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs